Health Care — Presented by Organon — Toddlers, infants now eligible for bivalent booster

View Online    Health Care Health Care   PRESENTED BY ORGANON Toddlers, infants now eligible for bivalent booster © AP You may be cool, but do you have a license to own a unicorn like this lucky Los Angeles girl?   Today in health, the FDA has expanded its emergency use authorization for the COVID-19 bivalent shots to include children as young as 6 months old.    Welcome to Overnight Health Care, where we're following the latest moves on policy and news affecting your health. For The Hill, we're Nathaniel Weixel and Joseph Choi. Someone forward you this newsletter? Subscribe here. Bivalent booster OKed for kids 6 months and older © AP The Food and Drug Administration (FDA) on Thursday announced it has expanded the emergency use authorization for the bivalent COVID-19 vaccine to include children between the ages of 6 months and 5 years. Children older than 6 months who have received the primary two-dose coronavirus vaccines from Moderna are now eligible to receive the bivalent booster designed to protect against omicron subvariants of the virus. Kids who have not yet started on the primary series of Pfizer's original coronavirus vaccines, which is administered in three doses for this younger age range, or have not yet received the final third dose, are also eligible for the bivalent shot. "As this virus has changed, and immunity from previous COVID-19 vaccination wanes, the more people who keep up to date on COVID-19 vaccinations, the more benefit there will be for individuals, families and public health by helping prevent severe illnesses, hospitalizations, and deaths," FDA Commissioner Robert Califf said in a statement.   According to the most up-to-date federal data, the BQ.1 and BQ.1.1 omicron subvariants are the two most common forms of the coronavirus circulating in the U.S. right now, collectively accounting for more than 60 percent of cases.    The bivalent shots are expected to still be effective against these strains, as they descend from the BA.4 and BA.5 omicron subvariants.    Read more here.  A MESSAGE FROM ORGANON Organon CEO: Give Women a Way Out of Contraceptive Deserts "Contraception deserts" put millions of women at risk of unintended pregnancies writes Kevin Ali, Organon CEO, who urges public officials to recognize the severity of this crisis and remove structural barriers to family planning. Senate Dems introduce bill funding travel for abortion © Victoria Sarno Jordan, The Hill Senate Democrats on Thursday introduced a bill that would help fund expenses for women who need to travel to undergo abortion procedures.    Sens. Tammy Baldwin (D-Wis.) and Patty Murray (D-Wa.) are introducing the Reproductive Health Travel Fund Act. The bill would authorize $350 million annually in grants over the next five years for organizations and abortion funds to help cover the cost of patients' travel for the procedure.   "Right now in states across the country, Americans are unable to make their own health care decisions," said Baldwin in a statement. "Women in states like Wisconsin are being forced to travel out of state just to see a doctor for critical health care, including abortion. And for too many, the cost of travel, child care, overnight housing, and time away from work puts safe, comprehensive reproductive care totally out of reach."  The funds would include associated expenses for lodging, child care and meals during the travel — as well as translation and patient education services.   The Journal of the American Medical Association found in a recent study that the average travel time for women seeking abortion services has more than tripled since the fall of Roe in June.   Baldwin and Murray's bill would have the Treasury secretary award the grants to nonprofits, community-based organizations and other eligible entities that help women access the procedure, with priority given to groups that serve women from areas where abortion care is banned or restricted.   Read more here. JYNNEOS OFFERED STRONG PROTECTION AGAINST MPOX INFECTION  Vaccination with the Jynneos smallpox vaccine was found to offer strong protection against mpox infection after one or two doses, according to a study conducted by the Centers for Disease Control and Prevention (CDC), providing some of the first clinical evidence on the efficacy of the shot used to fight back against the mpox outbreak this year. New data released in the CDC's Morbidity and Mortality Weekly Report found that the incidence of mpox infections among unvaccinated people was nearly 10 times higher when compared to the incidence rate among fully vaccinated individuals, and 7.4 times higher when compared to those who had received only one dose. The CDC acknowledged that more data was still needed to fully determine the impact of Jynneos against mpox, which was formerly known as monkeypox, but stated that this study indicated the drug's efficacy.  The CDC noted in its weekly report that the analysis of cases did not suggest a difference in protection between intradermal shots and subcutaneous ones, which are administered into the muscle and include a full dose of the vaccine like most other immunization injections.    Read more here.  VA HIRING MORE STAFF TO HANDLE TOXIC EXPOSURE CLAIMS The Department of Veterans Affairs (VA) and the Veterans Benefits Administration (VBA) will be adding staff to keep up with claims made by veterans through a recently passed bill to expand benefits for veterans exposed to toxins during their military service.   Joshua Jacobs, senior advisor performing the delegable duties of the under secretary for benefits of the Department of Veterans Affairs, said hiring was a key part of the VA's plan to accommodate the expected increase in benefits claimed through the PACT Act, during a hearing held by the House Committee on Veterans' Affairs.   "We are focused on hiring efforts up and down the organization," said Jacobs. "VBA has been preparing for PACT Act implementation since last year, hiring approximately 2,000 additional employees."   The PACT Act was created with the goal of expanding access to care and benefits from the VA to the 3.5 million veterans who served after the Sept. 11, 2001, terrorist attack and were exposed to toxic burn pits. Since it was passed in August, there have been many concerns about how the VA will make a smooth transition to implement the law without disrupting the department's other services.   The VA is set to start processing Promise to Address Comprehensive Toxics (PACT) Act claims on Jan. 1, 2023.     Read more here. Congress may lose chance to pass bipartisan pot bill © AP Lawmakers are facing a rapidly closing window to get key marijuana legislation across the finish line in the lame-duck session.    Despite fetching broad bipartisan support in the House and Senate, opposition from GOP leadership and a tightening timeline is chipping away at the bill's chances of passage.    The measure, called the SAFE Banking Act, would undo federal restrictions that discourage banks and other financial institutions from offering services to legally operating cannabis businesses.    What Congress is saying:  "We still got amendments on the floor. We still got a continuing resolution," Sen. Jeff Merkley (D-Ore.), who has also been leading efforts pushing the bill in the upper chamber, told The Hill on Wednesday. "We may have an omnibus. Not giving up on this Congress." "We've got nine [GOP] co-sponsors and probably some other Republicans who support it that aren't on the bill. So, there's some support for it," Sen. Steve Daines (R-Mont.), a lead negotiator for the bill, told The Hill, saying he is hopeful that the measure will be included in a potential government funding omnibus. "We get a lot of bad legislation when we do that, and the bad outweighs the good," Sen. Cynthia Lummis (R-Wyo.), one of the co-sponsors for the marijuana banking bill, told The Hill. "So, I don't want it on the omnibus, and I don't want non-defense items hooked to the NDAA."  Though the bill has Republican backers even outside those co-sponsoring the measure, there is still pushback within the caucus, party members say. Among the loudest has been Senate Minority Leader Mitch McConnell (R-Ky.), who this week knocked the bill as a measure that aims to make "our financial system more sympathetic to illegal drugs."    Read more here.  A MESSAGE FROM ORGANON Organon CEO: Give Women a Way Out of Contraceptive Deserts  "Contraception deserts" put millions of women at risk of unintended pregnancies writes Kevin Ali, Organon CEO, who urges public officials to recognize the severity of this crisis and remove structural barriers to family planning. WHAT WE'RE READING Congress has a chance to close the FDA's Theranos loophole (Stat)  Factory workers across the U.S. say they were exposed to asbestos on the job (NPR)  More states to consider extending postpartum Medicaid coverage beyond two months (Kaiser Health News)  STATE BY STATE At least 63 children are sick with measles in Ohio (ABC News)  Cases of canine flu surge in Texas, what to watch out for (KXAN)  State health department braces for impending hospital crisis (Mississippi Today) That's it for today, thanks for reading. Check out The Hill's Health Care page for the latest news and coverage. See you tomorrow. Sign up for Health Care Privacy Policy  |  Manage Subscriptions  |  Unsubscribe Sign Up for Other Newsletters 1625 K Street NW, 9th Floor, Washington, DC 20006 © 1998 - 2022 Nexstar Media Inc. | All Rights Reserved.